(Q45030233)

8 December 2017

title

Acute vigabatrin retinotoxicity in albino rats depends on light but not GABA. (English)

1 reference

8 December 2017

1 reference

2

1 reference

8 December 2017

5

Charles F Zorumski

1 reference

8 December 2017

1

Yukitoshi Izumi

1 reference

8 December 2017

3

Ann M Benz

1 reference

8 December 2017

Masayo Izumi

4

1 reference

8 December 2017

Liu Lin Thio

series ordinal

6

1 reference

8 December 2017

publication date

1 September 2004

1 reference

8 December 2017

1 reference

8 December 2017

volume

45

1 reference

8 December 2017

issue

9

1 reference

8 December 2017

page(s)

1043-1048

1 reference

Vigabatrin for tuberous sclerosis complex

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

Medical treatment of patients with infantile spasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

Recent advances in the treatment of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

Vigabatrin visual toxicity: evolution and dose dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

Visual field constriction in 91 Finnish children treated with vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

Symptomatic and asymptomatic visual loss in patients taking vigabatrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

Patients treated with vigabatrin exhibit central visual function loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

A controlled study comparing visual function in patients treated with vigabatrin and tiagabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

Severe persistent visual field constriction associated with vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

Long term changes in the visual fields of patients with temporal lobe epilepsy using vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

Vigabatrin-associated visual field constriction in a longitudinal series. Reversibility suggested after drug withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

Peripheral retinal dysfunction in patients taking vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

The effects of vigabatrin on electrophysiology and visual fields in epileptics: a controlled study with a discussion of possible mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

Retinal function abnormalities in patients treated with vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

Visual field loss associated with vigabatrin: pathological correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

An ex vivo rat retinal preparation for excitotoxicity studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

Visual field constriction: accumulation of vigabatrin but not tiagabine in the retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

Epilepsy patients treated with vigabatrin exhibit reduced ocular blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.01004.X

10.1111/J.0013-9580.2004.01004.X

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference